Protagonist Therapeutics, Inc
Protagonist Therapeutics, Inc., a biopharmaceutical company, has made significant strides in the development of peptide-based new chemical entities, with rusfertide and JNJ-2113 leading the charge in their clinical development stages. This review delves into the company's 10-K filing for 2023, pr...
This post is for subscribers only
Already have an account? Sign in.